Lincoln Pharmaceuticals Limited (LINCOLN.NS)

INR 873.9

(1.21%)

Market Cap (In INR)

17.5 Billion

Revenue (In INR)

5.8 Billion

Net Income (In INR)

933.04 Million

Avg. Volume

105.65 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
534.8-979.5
PE
-
EPS
-
Beta Value
0.677
ISIN
INE405C01035
CUSIP
Y5286Y136
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Mahendrabhai Gulabdas Patel B.A, LLB
Employee Count
-
Website
https://www.lincolnpharma.com
Ipo Date
2015-12-17
Details
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.

More Stocks